Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Most linked-to pages

From GxPlex

Jump to: navigation, search

Showing below up to 50 results in range #1,401 to #1,450.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Reference:DEU Bundestag - Sachstand zur Aufbewahrung von Patientenakten in der ambulanten Praxis Fristen und Form 01-Mar-2021 - (4 links)
  2. Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 11 (4 links)
  3. Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.4 (4 links)
  4. Reference:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 4 (4 links)
  5. Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 49 (4 links)
  6. Reference:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 Appendix I (4 links)
  7. Reference:EU Eudralex - volume 4 GMP Guidelines Chapter 4 Jan-2011 4 (4 links)
  8. Reference:EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838 - (4 links)
  9. Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex VIII (4 links)
  10. Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 14 (4 links)
  11. Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 62 (4 links)
  12. Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex VIII (4 links)
  13. Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 14 (4 links)
  14. Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 58 Paragraph 5 (j) (4 links)
  15. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 21 (4 links)
  16. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 22 (4 links)
  17. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 28 Paragraph 1 (f) (4 links)
  18. Reference:EU Regulation (EU) 910/2014 - electronic identification 17-Sep-2014 - (4 links)
  19. Reference:EU Regulation (EU) 910/2014 - electronic identification 17-Sep-2014 Article 3 Paragraph 10 (4 links)
  20. Reference:GBR IRAS - Integrated Research Application System 28-Jan-2025 IRAS (4 links)
  21. Reference:GBR IRAS - Integrated Research Application System 28-Jan-2025 Templates (4 links)
  22. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 7-10 (4 links)
  23. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Part 1 Article 2 (4 links)
  24. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 (4 links)
  25. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 7 (4 links)
  26. Reference:ICH ICH E3 Guideline 1995 - (4 links)
  27. Reference:ICH ICH E6 Guideline R3 (2025) Appendix A (4 links)
  28. Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 16 (4 links)
  29. Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Blinding/Masking (4 links)
  30. Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Data Integrity (4 links)
  31. Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Metadata (4 links)
  32. Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Protocol Amendment (4 links)
  33. Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Randomisation (4 links)
  34. Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Signature (4 links)
  35. Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3 (4 links)
  36. Reference:ICH ICH E8 Guideline R1 (2021) - (4 links)
  37. Reference:ICH ICH E9 Guideline 1998 Glossary - Double-Dummy (4 links)
  38. Reference:INT ISPE - GPP Revision 3 (2015) II. (4 links)
  39. Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex A - CIP (4 links)
  40. Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex A - medical device-001 (4 links)
  41. Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex A - medical device-002 (4 links)
  42. Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex A A.7 (4 links)
  43. Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex F (4 links)
  44. Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex J (4 links)
  45. Reference:N.A. SPIRIT 2013 - Chan et al. 2013 - (4 links)
  46. Reference:N.A. Transcelerate GCP mutual recognition programm FAQ 21-May-2025 - (4 links)
  47. Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.25 (e) (4 links)
  48. Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (h) (4 links)
  49. Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (i) (4 links)
  50. Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (m) (4 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://gxplex.org/index.php?title=Special:MostLinkedPages"